Freestone Capital Holdings »

Arbutus Biopharma shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.7M 546k 3.09

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Put Option (AMZN)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Nike CL B (NKE)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Freestone Capital Holdings

Top funds holding Arbutus Biopharma

Morgan Stanley
Whitefort Capital Management
BlackRock
BlackRock
Two Seas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
BlackBarn Capital Partners
Rubric Capital Management
Squarepoint Ops
Advisor Group Holdings
Northern Trust
Charles Schwab Investment Management
Hudson Bay Capital Management

View all funds holding Arbutus Biopharma